Shenyang, China

Peng Yang

This inventor holds 1 USPTO granted patent. Top assignee: University of Saskatchewan. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Yang. Retrieved from https://idiyas.com/inventor/peng-yang-eshgxcpa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Drug Delivery by Peng Yang

Introduction

Peng Yang is an accomplished inventor based in Shenyang, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. His innovative work focuses on enhancing the efficacy of drug delivery agents through novel chemical compositions.

Latest Patents

Peng Yang holds a patent titled "Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same." This patent relates to cyclodextrin-based drug delivery agents that feature a cyclodextrin moiety covalently linked to a gemini surfactant moiety. The pharmaceutical compositions that include this drug delivery agent and a therapeutic agent are also disclosed. He has 1 patent to his name.

Career Highlights

Peng Yang is affiliated with the University of Saskatchewan, where he continues to advance research in drug delivery technologies. His work is pivotal in developing more effective pharmaceutical formulations that can improve patient outcomes.

Collaborations

He collaborates with notable colleagues, including Ildiko Badea and Ronald Verrall, to further enhance the impact of his research in the pharmaceutical field.

Conclusion

Peng Yang's innovative contributions to drug delivery systems exemplify the importance of research in improving therapeutic efficacy. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…